Review Note
Last Update: 01/11/2024 01:19 AM
Current Deck: Rohanki::IMIS::Week 2::Inflammatory Skin Disorders
PublishedCurrently Published Content
Front
MOA of apremilast
Back
Phosphodiesterase 4 inhibitor
• Prevents cyclic AMP degradation within immune cells, decreasing overall
immune activation
Used for psoriasis
Used for psoriasis
Current Tags:
Pending Suggestions
No pending suggestions for this note.